|
|
| | ANTI-SENTRIN-2 Basic information |
| Product Name: | ANTI-SENTRIN-2 | | Synonyms: | ANTI-SUMO-3;ANTI-SMT3B;ANTI-SENTRIN-2;RABBIT ANTI-HUMAN SUMO3;Anti-SUMO3 (C-term P94) antibody produced in rabbit;Anti-Ubiquitin-like protein SMT3A;Anti-SMT3 homolog 1;Anti-SUMO3 (C-term) antibody produced in rabbit | | CAS: | | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![ANTI-SENTRIN-2 Structure]() |
| | ANTI-SENTRIN-2 Chemical Properties |
| storage temp. | -20°C | | form | buffered aqueous solution |
| | ANTI-SENTRIN-2 Usage And Synthesis |
| General Description | Covalent modification of target lysines by SUMO (small ubiquitin-like modifier) modulates processes such as protein localization, transcription, nuclear transport, mitosis, DNA replication and repair, signal transduction, and viral reproduction. SUMO does not seem to be involved in protein degradation and may in fact function as an antagonist of ubiquitin in the degradation process. The SUMO family consists of SUMO1 and closely related homologs SUMO2, SUMO3, and SUMO4. Sumoylation has been shown to regulate a wide range of proteins, including MDM2, PIAS, PML, RanGAP1, RanBP2, p53, p73, HIPK2, TEL, c-Jun, Fas, Daxx, TNFRI, Topo-I, Topo-II, PARK2, WRN, Sp100, IkB-alpha, Androgen receptor (AR), GLUT1/4, CaMK, DNMT3B, TDG, HIF1A, CHD3, EXOSC9, RAD51, and viral targets such as CMV-IE1/2, EBV-BZLF1, and HPV/BPV-E1. |
| | ANTI-SENTRIN-2 Preparation Products And Raw materials |
|